News | June 21, 2010

New Study Shows Erectile Dysfunction Could Be Marker for Heart Attack

June 21, 2010 – Seven out of 10 men admitted to hospital for a heart attack, or acute ST segment elevation myocardial infarction (STEMI), had erectile dysfunction (ED) in the six months prior to their admission, according to new data presented last week at the World Congress of Cardiology Scientific Sessions in Beijing, China.

A year-long study conducted in 2009 involving 111 sexually active men admitted for STEMI at the University Malaya Medical Centre demonstrated that 75.7 percent had experienced ED in the six months prior to being hospitalized, and all patients with a prior history of ischemic heart disease had ED. Moreover, 24.7 percent of the 81 sexually inactive men that were not recruited to the study reported complete ED for more than six months prior to screening.

ED and coronary artery disease (CAD) share many common risk factors and are closely related. Atherosclerosis, the root cause of CAD and ED, is a generalized inflammatory disorder that progresses at a similar rate throughout the vasculature of the body. Therefore, it is thought that ED should precede CAD since the penile arteries are considerably smaller than the coronary arteries.

“This study demonstrates that we should consider patients with evidence of ED to be of very high risk for development of future acute coronary syndromes. Interestingly, the study also found that all patients with a prior history of heart attack and ED presented with recurrent heart attacks. Therefore, we should screen and treat such patients very aggressively,” said Dr. S. V. Ramesh, University of Malay Medical Centre, Kuala Lumpur, Malaysia. “Moreover, men who are not sexually active should also be closely assessed, as a quarter of them have complete ED which warrants treatment, and this may also be a harbinger for CAD.”

A total of 219 men were admitted for STEMI to the coronary care unit from April 2008 to February 2009. Of these, 192 were screened and only 111 who were sexually active within the last six months were recruited for the assessment of ED using the IIEF-5 questionnaire. Other indices studied include the cardiovascular (CV) risk factors, body measurements, blood results and coronary angiographic findings.

For more information: www.worldcardiocongress.org

Related Content

New FDA Proposed Rule Alters Informed Consent for Clinical Studies
News | Cardiovascular Clinical Studies | November 19, 2018
The U.S. Food and Drug Administration (FDA) is proposing to add an exception to informed consent requirements for...
A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development. #SCAI, #SCAI2018

A key slide from Elnabawi's presentation, showing cardiac CT plaque evaluations, showing the impact of psoriasis medication on coronary plaques at baseline and one year of treatment. It shows a reversal of vulnerable plaque development.  

Feature | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 – New clinical evidance shows common therapy options for psoriasis (PSO), a chronic inflammatory skin di
Intravenous Drug Use is Causing Rise in Heart Valve Infections, Healthcare Costs. #SCAI, #SCAI2018
News | Cardiovascular Clinical Studies | May 14, 2018
May 14, 2018 — The opioid drug epidemic is impacting cardiology, with a new study finding the number of patients hosp
Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
Overlay Init